keyword
https://read.qxmd.com/read/38529648/psychometric-evaluation-of-the-multidimensional-scale-uremic-pruritus-in-dialysis-patients-up-dial-comparison-in-hemodialysis-and-peritoneal-dialysis-patients-with-chronic-pruritus
#21
JOURNAL ARTICLE
Surapon Nochaiwong, Chidchanok Ruengorn, Kednapa Thavorn, Kajohnsak Noppakun, Manish M Sood, Greg A Knoll, Jonathan A Bernstein, Jacek C Szepietowski, Mati Chuamanochan
BACKGROUND: High-quality patient-reported outcome (PRO) measures for dialysis patients with chronic pruritus are urgently needed. However, no known, well-validated multidimensional tools have been investigated to measure pruritus symptoms in dialysis patients. OBJECTIVES: To examine the psychometric properties of a multidimensional tool of chronic pruritus, the Uremic Pruritus in Dialysis (UP-Dial) 14-item, by comparing hemodialysis and peritoneal dialysis modality...
March 26, 2024: British Journal of Dermatology
https://read.qxmd.com/read/38529121/is-the-cost-of-the-new-home-dialysis-techniques-still-advantageous-compared-to-in-center-hemodialysis-an-italian-single-center-analysis-and-comparison-with-experiences-from-western-countries
#22
JOURNAL ARTICLE
Gian Maria Iadarola, Elisa Giorda, Marco Borca, Daniela Morero, Savino Sciascia, Dario Roccatello
INTRODUCTION: Potential advantages of home dialysis remained a questionable issue. Three main factors have to be considered: the progressive reduction in the cost of consumables for in-Center hemodialysis (IC-HD), the widespread use of incremental Peritoneal Dialysis (PD), and the renewed interest in home hemodialysis (H-HD) in the pandemic era. Registries data on prevalence of dialysis modalities generally report widespread underemployment of home dialysis despite PD and H-HD could potentially provide clinical benefits, improve quality of life, and contrast the diffusion of new infection among immunocompromised patients...
2024: Frontiers in Medicine
https://read.qxmd.com/read/38525052/the-tunnelled-atrial-catheter-a-promising-solution-for-vascular-capital-depletion-in-dialysis-despite-associated-thrombi
#23
Meriam Hajji, Salah Saied, Ikram Mami, Yassine Khadhar, Tasnim Ben Ayed, Imen Gorsane, Fethi Ben Hamida, Jalel Ziadi, Mohamed Karim Zouaghi, Ezzeddine Abderrahim
INTRODUCTION: Longer survival in dialysis led to a higher incidence of vascular access complications and failure. With the limited access to kidney transplantation programs and peritoneal dialysis, exhaustion of vascular access for hemodialysis is an increasingly common situation. Among the available options, atrial tunneled dialysis catheter (ATDC) has been reported as an effective vascular access in this population. Methodology . We report the experiences of two nephrology centers in Tunis with ATDC as an ultimate vascular access for dialysis...
2024: Case Reports in Nephrology
https://read.qxmd.com/read/38524642/durvalumab-plus-carboplatin-etoposide-treatment-in-a-patient-with-small-cell-lung-cancer-on-hemodialysis-a-case-report-and-literature-review
#24
JOURNAL ARTICLE
Futoshi Ushijima, Tetsunari Hase, Yuki Yamashita, Hangsoo Kim, Tomoya Shimokata, Chiaki Kondo, Tomonori Sato, Tomoya Baba, Shohei Watanabe, Keisuke Futamura, Yuichi Ando, Masashi Mizuno, Makoto Ishii
Little is known about the efficacy and safety of durvalumab plus carboplatin-etoposide treatment in patients with extensive-disease (ED) small-cell lung cancer (SCLC) on hemodialysis. Here, we present a case of a 67-year-old man with pleuroperitoneal communication on continuous ambulatory peritoneal dialysis who was diagnosed with ED-SCLC based on a cytological analysis of the peritoneal fluid. He was switched from peritoneal dialysis to hemodialysis and received durvalumab (1500 mg/body on day 1) plus carboplatin (area under the concentration-time curve = 5, 125 mg on day 1) and etoposide (50 mg/m2 on days 1 and 3) as first-line therapy...
April 2024: International cancer conference journal
https://read.qxmd.com/read/38522414/serum-myostatin-at-dialysis-initiation-may-predict-1-year-mortality-and-hospitalization
#25
JOURNAL ARTICLE
Midori Sakashita, Yoshifumi Hamasaki, Rikako Oki, Yohei Komaru, Yoshihisa Miyamoto, Teruhiko Yoshida, Ryo Matsuura, Kent Doi, Masaomi Nangaku
OBJECTIVE: Myostatin, which is known as a negative skeleton muscle regulator, is associated with mortality in maintenance hemodialysis patients. However, the significance of serum myostatin concentrations at dialysis initiation has not been established. We investigated the relation between serum myostatin concentrations and mortality or hospitalization within one year in incident dialysis patients. METHODS: After a patient initiating hemodialysis or peritoneal dialysis during 2016-2018 was enrolled, the patient's serum myostatin at dialysis initiation was measured...
March 23, 2024: Nephron
https://read.qxmd.com/read/38514529/effect-of-proactive-combination-therapy-with-peritoneal-dialysis-and-hemodialysis-on-technique-survival-and-mortality
#26
JOURNAL ARTICLE
Kei Nagai, Atsushi Ueda
PURPOSE: Clinically relevant evidence for the timing of starting combination therapy with peritoneal dialysis and hemodialysis remains scarce. We retrospectively examined whether combination therapy during the induction phase of dialysis prolongs peritoneal dialysis duration. METHODS: This retrospective study includes 160 patients who underwent combination therapy from 20 dialysis facilities. Four groups were categorized: combination at peritoneal dialysis induction (n = 12, Proactive combination group), and combination following peritoneal dialysis durations of < 2 years (n = 65), 2-5 years (n = 70), or > 5 years (n = 13)...
March 22, 2024: Journal of Artificial Organs: the Official Journal of the Japanese Society for Artificial Organs
https://read.qxmd.com/read/38507158/tunnel-ultrasound-can-guide-the-use-of-peritoneal-dialysis-catheter-exit-site-relocation-by-external-splicing-and-cuff-removal-in-refractory-tunnel-infection
#27
JOURNAL ARTICLE
Luca Nardelli, Antonio Scalamogna, Federica Tripodi, Chiara De Liso, Carlo Alfieri, Giuseppe Castellano
BACKGROUND: Peritoneal dialysis (PD) catheter related infections continue to be a major cause of morbidity and transfer to hemodialysis (HD) in PD patients. The treatment of tunnel infection (TI) could be challenging, especially when the infection involves the superficial cuff requiring the removal of the catheter. To spare the patient the loss of the catheter and the transfer to HD, several mini-invasive surgical techniques have been proposed as rescue therapy. Furthermore, nowadays, the rapid growth of digital technology has enormously increased the diagnostic sensibility of the echo signal allowing to accurately defines the extent of the infectious process along the PD catheter tunnel...
March 20, 2024: International Urology and Nephrology
https://read.qxmd.com/read/38503885/real-world-evidence-of-constipation-and-laxative-use-in-the-korean-population-with-chronic-kidney-disease-from-a-common-data-model
#28
JOURNAL ARTICLE
Kipyo Kim, Ji-Eun Kim, Jae Ho Kim, Seong Hee Ahn, Chai Young Jung, Seun Deuk Hwang, Seoung Woo Lee, Joon Ho Song
Constipation is a highly prevalent gastrointestinal disorder in patients with chronic kidney disease (CKD). However, our understanding of its epidemiology and management in CKD is limited. We aimed to explore real-world data on constipation and laxative use in patients with CKD in a nationwide population-based cohort from the Korean Health Insurance Review and Assessment-National Patient Sample database. This study analyzed retrospective health claims data in Korea from 2012 to 2017 that were transformed into the Observational Medical Outcomes Partnership Common Data Model...
March 19, 2024: Scientific Reports
https://read.qxmd.com/read/38497953/arteriovenous-access-for-hemodialysis-a-review
#29
JOURNAL ARTICLE
Charmaine E Lok, Thomas S Huber, Ani Orchanian-Cheff, Dheeraj K Rajan
IMPORTANCE: Hemodialysis requires reliable vascular access to the patient's blood circulation, such as an arteriovenous access in the form of an autogenous arteriovenous fistula or nonautogenous arteriovenous graft. This Review addresses key issues associated with the construction and maintenance of hemodialysis arteriovenous access. OBSERVATIONS: All patients with kidney failure should have an individualized strategy (known as Patient Life-Plan, Access Needs, or PLAN) for kidney replacement therapy and dialysis access, including contingency plans for access failure...
March 18, 2024: JAMA
https://read.qxmd.com/read/38496155/profile-of-acute-kidney-injury-in-the-pediatric-age-group-in-a-tertiary-care-hospital-a-prospective-observational-study
#30
JOURNAL ARTICLE
Ishan Kapil, Anil Kumar Goel, Manas R Sahoo
BACKGROUND AND OBJECTIVES: Acute kidney injury (AKI) is a menace in the pediatric intensive care unit (PICU) and is responsible for significant morbidity and mortality all over the world. There are limited data available on pediatric AKI in central India. Our primary objective is to determine the clinical, etiological, and outcome profile of AKI in the pediatric age group of 3 months to 15 years admitted to the All India Institute of Medical Sciences (AIIMS), Raipur. The secondary objective(s) is to predict the association of mortality in children diagnosed with AKI and to estimate the number of patients developing chronic kidney disease (CKD) at three-month follow-up...
February 2024: Curēus
https://read.qxmd.com/read/38492168/residents-satisfaction-and-suggestions-to-improve-nephrology-residency-in-italy-and-comparison-with-the-organization-in-other-european-countries
#31
JOURNAL ARTICLE
Adolfo Marco Perrotta, Silverio Rotondi, Maria Amicone, Irene Cirella, Rossella Siligato, Simone Fontana, Carmen Sivo, Anna Rita Vestri, Giovanni Gambaro, Giorgina Barbara Piccoli, Sandro Mazzaferro
BACKGROUND: In Italy, nephrology residency is available in twenty-one nephrology schools, each with its own strengths and weaknesses. The present study is aimed at exploring the residents' satisfaction with their training programs. METHODS: Between April 20th and May 19th, 2021, a questionnaire on residency satisfaction consisting of 49 items was sent to 586 residents and 175 recently certified specialists (qualified to practice as nephrologists in 2019 and 2020), with a response rate of 81% and 51%, respectively...
March 16, 2024: Journal of Nephrology
https://read.qxmd.com/read/38490516/role-of-peritoneal-equilibration-test-in-assessing-folate-transport-during-peritoneal-dialysis
#32
JOURNAL ARTICLE
Yu-Ling Lin, Yi-Che Lee, Chih-Chung Lee, Mei-Hsuan Wu
BACKGROUND: Low plasma folate levels have been reported in patients undergoing hemodialysis and peritoneal dialysis (PD) in clinical studies. However, folate transport has never been mentioned as a factor contributing to low plasma folate levels in patients undergoing PD. The peritoneal equilibrium test (PET) assesses the plasma creatinine level and glucose transport abilities. This study aimed to evaluate the association between plasma folate levels and folate transport during PD based on PET grades...
March 13, 2024: Journal of Renal Nutrition
https://read.qxmd.com/read/38482569/long-term-mortality-in-patients-with-end-stage-renal-disease-undergoing-hemodialysis-and-peritoneal-dialysis-a-propensity-score-matching-retrospective-study
#33
JOURNAL ARTICLE
Pengjie Zhang, Liru Xun, Nan Bao, Ding Tong, Bin Duan, Du Peng
BACKGROUND: Hemodialysis (HD) and peritoneal dialysis (PD) are effective ways to treat end-stage renal disease (ERSD). This study aimed to investigate the differences in survival and the factors that influence it in patients with end-stage renal disease treated with HD or PD. METHODS: We retrospectively analyzed factors related to all-cause death with renal replacement therapy and compared the long-term mortality between HD and PD strategies in patients with ESRD who started HD or PD treatment in our renal HD center between January 1, 2008, and December 1, 2021...
December 2024: Renal Failure
https://read.qxmd.com/read/38481507/novel-colorimetric-and-light-scatter-methods-to-identify-and-manage-peritoneal-dialysis-associated-peritonitis-at-the-point-of-care
#34
JOURNAL ARTICLE
Nishal Govindji-Bhatt, Stephnie M Kennedy, Michael G Barker, Darren Kell, Duncan Henderson, Nicholas Goddard, Ana Yepes Garcia, Adam S Milner, Tom Willett, Ryan Griffiths, Peter Foster, William Kilgallon, Rachel Cant, Christopher G Knight, David Lewis, Richard Corbett, Habib Akbani, Graham Woodrow, Bhrigu Sood, Osasuyi Iyasere, Simon Davies, Junaid Qazi, Anand Vardhan, Laura Gillis, Martin Wilkie, Curtis B Dobson
INTRODUCTION: Peritoneal dialysis (PD)-related peritonitis (PDRP) is a common cause of transfer to hemodialysis, patient morbidity, and is a risk factor for mortality. Associated patient anxiety can deter selection of PD for renal replacement therapy. Diagnosis relies on hospital laboratory tests; however, this might be achieved earlier if such information was available at the point-of-care (POC), thereby significantly improving outcomes. The presence of culturable microbes and the concentration of leukocytes in effluent both aid peritonitis diagnosis, as specified in the International Society for Peritoneal Dialysis (ISPD) diagnostic guidelines...
March 2024: KI Reports
https://read.qxmd.com/read/38477178/comparison-of-unplanned-urgent-start-versus-conventional-start-peritoneal-dialysis-a-systematic-review-and-meta-analysis
#35
REVIEW
Yunfen Xu, Weizhong Jiang
The timing of peritoneal dialysis (PD) initiation, whether conventional-start (planned) or urgent-start (unplanned), may impact the outcomes of PD and the rate of associated complications in individuals with chronic kidney disease (CKD). The goal of this study was to evaluate the effects of unplanned/urgent-start PD versus conventional-start PD in this cohort of patients. Electronic search of MEDLINE (via PubMed), EMBASE, Cochrane Central Register of Controlled Trials (CENTRAL), and Scopus databases was done from inception until July 2023 for studies reporting outcomes of unplanned/urgent-start and conventional-start PD in CKD patients...
March 13, 2024: Seminars in Dialysis
https://read.qxmd.com/read/38472543/frequency-and-prognosis-of-peritoneal-dialysis-associated-peritonitis-in-children
#36
JOURNAL ARTICLE
Misaki Akiyama, Koichi Kamei, Kentaro Nishi, Tomoya Kaneda, Yuta Inoki, Kei Osaka, Mai Sato, Masao Ogura, Shuichi Ito
BACKGROUND: Peritonitis is the leading cause of peritoneal dialysis (PD) discontinuation. However, few data concern risk factors of peritonitis development and catheter removal caused by treatment failure in pediatric patients. METHODS: This single-center, retrospective study analyzed data from pediatric patients who underwent chronic PD between March 2002 and June 2022. The incidence rates of peritonitis by the person-year method were calculated, and they were stratified by patient age groups...
March 12, 2024: Clinical and Experimental Nephrology
https://read.qxmd.com/read/38470704/functionality-and-usability-of-mhealth-apps-in-patients-with-peritoneal-dialysis-a-systematic-review
#37
REVIEW
Shu-Mei Chao, Chao-Kuei Pan, Ming-Ling Wang, Yu-Wen Fang, Shu-Fen Chen
mHealth has been utilized in the care of patients with chronic kidney disease, allowing the collection of patient health-related data, offering disease-related information, enabling the tracking and recording of biochemical parameters, and enabling communication with healthcare providers in real time through applications. mHealth may improve the health outcomes in patients with peritoneal dialysis. This systematic review aimed to summarize evidence regarding the functionality and usability of mHealth apps in patients with peritoneal dialysis...
March 5, 2024: Healthcare (Basel, Switzerland)
https://read.qxmd.com/read/38468403/health-related-quality-of-life-for-pediatric-patients-with-end-stage-kidney-disease-a-systematic-review-and-meta-analysis-of-the-pediatric-quality-of-life-inventory-pedsql
#38
JOURNAL ARTICLE
Kush Doshi, Rupesh Raina, Kar Hui Ng, Vera Koch, Girish C Bhatt, Arwa Nada, Brian Foresi, Sibee Sambandam Kamalakkannan, Mignon McCulloch, Sidharth Sethi, Maria Díaz-González de Ferris
INTRODUCTION: Health-related quality of life (HRQoL) studies demonstrate the impact of end-stage renal disease (ESRD) on the physical and psychosocial development of children. While several instruments are used to measure HRQoL, few have standardized domains specific to pediatric ESRD. This review examines current evidence on self and proxy-reported HRQoL among pediatric patients with ESRD, based on the Pediatric Quality of Life Inventory (PedsQL) questionnaires. METHODS: Following PRISMA guidelines, we conducted a systematic review and meta-analysis on HRQoL using the PedsQL 4...
March 11, 2024: Hemodialysis International
https://read.qxmd.com/read/38457030/cellular-and-humoral-immune-responses-to-covid-19-booster-vaccination-in-japanese-dialysis-patients
#39
JOURNAL ARTICLE
Ayumi Yoshifuji, Masataro Toda, Emi Oyama, Tetsuo Nakayama, Setsuko Mise-Omata, Kan Kikuchi, Mamoru Yoshizawa, Naohiko Kato, Haruki Wakai, Kiyoto Koibuchi, Kohkichi Morimoto, Yoshifumi Uwamino, Ho Namkoong, Ayako Shibata, Kaoru Wakabayashi, Motoko Fujino, Motoaki Komatsu, Naoki Mochizuki, Norihiko Kondo, Akihiko Yoshimura, Naoki Hasegawa, Munekazu Ryuzaki
BACKGROUND: Dialysis patients are susceptible to developing severe coronavirus disease 2019 (COVID-19) due to hypoimmunity. Antibody titers against severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) after the primary vaccinations are lower in hemodialysis (HD) patients than in healthy individuals. This study aimed to evaluate the effect of a SARS-CoV-2 booster vaccination in HD and peritoneal dialysis (PD) patients based on antibody titers and cellular and humoral immunity. METHODS: Participants of the control, HD, and PD groups were recruited from 12 facilities...
March 8, 2024: Clinical and Experimental Nephrology
https://read.qxmd.com/read/38448887/peritoneal-dialysis-vs-hemodialysis-among-patients-with-end-stage-renal-disease-in-iran-which-is-more-cost-effective
#40
JOURNAL ARTICLE
Mahmood Yousefi, Satar Rezaei, Sakineh Hajebrahimi, Niloofar Falsafi, Fatemeh Keshvari-Shad
BACKGROUND: There is little economic evidence on different modalities among patients with end-stage renal disease (ESRD) in Iran. This study aimed to assess the cost-utility of peritoneal dialysis (PD) and hemodialysis (HD) among ESRD patients in Iran. METHODS: From the health system perspective and with a 10-year time horizon, we conducted a cost-utility analysis based on a Markov model to compare three strategies of PD and HD [the second scenario (30% PD, 70% HD), the third scenario (50% PD, 50% HD) and the fourth scenario (70% PD, 30% HD)] among ESRD patients with the current situation (PD, 3% vs...
March 6, 2024: BMC Nephrology
keyword
keyword
117518
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.